Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1981 results

Fed Circuit affirms GSK $107m patent loss

US20-11-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit rejected GlaxoSmithKline’s challenge of a $89.7 million verdict which found the drugmaker had infringed a dry-powder inhaler patent.

Medicure and Nexus agree Aggrastat generic licence

US20-11-2020Rory O'Neill

US cardiovascular therapies company Medicure has settled a patent infringement dispute with rival Nexus Pharmaceuticals.

Third Circuit under fire over FTC v AbbVie ruling

US18-11-2020Rory O'Neill

The US Federal Trade Commission and AbbVie both want a federal appeals court to rehear a lawsuit accusing the drug company of quashing competition through sham patent litigation.

GSK, Amgen want SCOTUS to protect genus claims

US18-11-2020Rory O'Neill

Patent law experts and pharmaceutical companies have lent their support to Merck Sharp & Dohme in its effort to confirm the patent-eligibility of genus claims at the US Supreme Court.

Daiichi and AstraZeneca fight back in cancer drug dispute with Seagen


Daiichi Sankyo and AstraZeneca have asked the US District Court for the District of Delaware for a declaration that their breast cancer treatment does not infringe a chemotherapy patent owned by biotechnology company Seagen.

Baxter sues B.Braun in revived kidney treatment patent dispute


American healthcare multinational Baxter has accused B.Braun of patent infringement and fraudulent misrepresentation in an on-going dispute over products used to treat acute kidney injury.

FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent


The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.

Fed Circuit cancels Bard patent loss

US12-11-2020Rory O'Neill

The US Court of Appeals for the Federal Circuit has cancelled a lower court ruling holding that a Bard patent for vascular access device was both not infringed and patent-ineligible.

Allied BioScience sues ex-CEO for holding IP hostage

US12-11-2020Muireann Bolger

Allied BioScience has accused its former CEO of holding the company's IP, including inventions relating to its COVID-19 antiviral disinfectant, to ransom so he can demand an unfair amount of compensation.

Milestone COVID-19 vaccine offers 90% protection

International10-11-2020Muireann Bolger

A coronavirus vaccine unveiled by pharmaceutical companies Pfizer and BioNTech can potentially prevent more than 90% of people from getting COVID-19, it has been announced.

Showing 1 to 10 of 1981 results